Ulrich Schopfer

2.6k total citations · 1 hit paper
34 papers, 1.8k citations indexed

About

Ulrich Schopfer is a scholar working on Molecular Biology, Organic Chemistry and Computational Theory and Mathematics. According to data from OpenAlex, Ulrich Schopfer has authored 34 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 12 papers in Organic Chemistry and 12 papers in Computational Theory and Mathematics. Recurrent topics in Ulrich Schopfer's work include Computational Drug Discovery Methods (12 papers), Analytical Chemistry and Chromatography (6 papers) and Molecular spectroscopy and chirality (6 papers). Ulrich Schopfer is often cited by papers focused on Computational Drug Discovery Methods (12 papers), Analytical Chemistry and Chromatography (6 papers) and Molecular spectroscopy and chirality (6 papers). Ulrich Schopfer collaborates with scholars based in Switzerland, Germany and United States. Ulrich Schopfer's co-authors include Achim Schlapbach, Martyn Banks, Darren V. S. Green, Dragan A. Cirovic, Dejan Bojanic, G. Sitta Sittampalam, Jeff W. Paslay, William P. Janzen, Tina Garyantes and David Burns and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Nature Reviews Drug Discovery.

In The Last Decade

Ulrich Schopfer

33 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Impact of high-throughput screening in biomedical research

2011 920 citations Ricardo Macarrón, Martyn Banks et al. Nature Reviews Drug Discovery profile →

Peers

Countries citing papers authored by Ulrich Schopfer

Since Specialization

Citations

This map shows the geographic impact of Ulrich Schopfer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrich Schopfer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrich Schopfer more than expected).

Fields of papers citing papers by Ulrich Schopfer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrich Schopfer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrich Schopfer. The network helps show where Ulrich Schopfer may publish in the future.

Co-authorship network of co-authors of Ulrich Schopfer

This figure shows the co-authorship network connecting the top 25 collaborators of Ulrich Schopfer. A scholar is included among the top collaborators of Ulrich Schopfer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrich Schopfer. Ulrich Schopfer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Quantitative interaction analysis permits molecular insights into functional NOX4 NADPH oxidase heterodimer assembly 2018 ·Journal of Biological Chemistry ·Sharon O’Neill, (unknown), Lidija Kovačič, Suisheng Zhang, Jürgen Reinhardt, Dimitri Scholz, Ulrich Schopfer, Rochdi Bouhelal, Ulla G. Knaus	12
2	How Phenotypic Screening Influenced Drug Discovery: Lessons from Five Years of Practice 2017 ·Assay and Drug Development Technologies ·Dorothea Haasen, Ulrich Schopfer, Christophe Antczak, Chantale T. Guy, Florian Fuchs, Paul M. Selzer	44
3	High Throughput Random Mutagenesis and Single Molecule Real Time Sequencing of the Muscle Nicotinic Acetylcholine Receptor 2016 ·PLoS ONE ·Paul J. Groot‐Kormelink, Sandrine Ferrand, Nicholas Kelley, Anke Bill, Felix Freuler, (unknown), (unknown), Nicole Gerwin, Lucia G. Sivilotti, Loren Miraglia, Anthony P. Orth, Edward J. Oakeley, Ulrich Schopfer, Sandra Siehler	4
4	An Alternative Thiol-Reactive Dye to Analyze Ligand Interactions with the Chemokine Receptor CXCR2 Using a New Thermal Shift Assay Format 2015 ·SLAS DISCOVERY ·Christian Bergsdorf, Cédric Fiez-Vandal, David A. Sykes, (unknown), (unknown), Steven J. Charlton, Ulrich Schopfer, Johannes Ottl, Myriam Duckely	13
5	High-Throughput Screening Using iPSC-Derived Neuronal Progenitors to Identify Compounds Counteracting Epigenetic Gene Silencing in Fragile X Syndrome 2015 ·SLAS DISCOVERY ·Markus Kaufmann, Ansgar Schuffenhauer, Isabelle Fruh, Jessica L. Klein, (unknown), Pierre Rigo, Baltazar Gomez‐Mancilla, (unknown), Tewis Bouwmeester, Ulrich Schopfer, Matthias Müeller, Barna D. Fodor, Amanda Cobos‐Correa	69
6	Theoretical and Experimental Relationships between Percent Inhibition and IC50 Data Observed in High-Throughput Screening 2012 ·SLAS DISCOVERY ·(unknown), Ulrich Schopfer, Edgar Jacoby	27
7	HDL-like discs for assaying membrane proteins in drug discovery 2012 ·Biophysical Chemistry ·Cédric Fiez-Vandal, Lukas Leder, Felix Freuler, David A. Sykes, Steven J. Charlton, Sandra Siehler, Ulrich Schopfer, Myriam Duckely	6
8	Screening for Mevalonate Biosynthetic Pathway Inhibitors Using Sensitized Bacterial Strains 2011 ·SLAS DISCOVERY ·Sandrine Ferrand, Jianshi Tao, Xiaoyu Shen, (unknown), (unknown), J. Fraser Glickman, Ulrich Schopfer	9
9	Impact of high-throughput screening in biomedical research breakdown → 2011 ·Nature Reviews Drug Discovery ·Ricardo Macarrón, Martyn Banks, Dejan Bojanic, David Burns, Dragan A. Cirovic, Tina Garyantes, Darren V. S. Green, Robert Hertzberg, William P. Janzen, Jeff W. Paslay, Ulrich Schopfer, G. Sitta Sittampalam	920
10	Knowledge-Based Virtual Screening: Application to the MDM4/p53 Protein–Protein Interaction 2009 ·Methods in molecular biology ·Edgar Jacoby, Andreas Boettcher, Lorenz M. Mayr, Nathan Brown, Jeremy L. Jenkins, Joerg Kallen, (unknown), Ulrich Schopfer, Pascal Furet, Keiichi Masuya, Joanna Lisztwan	17
11	Hypothesis-Driven Screening 2009 ·Methods in molecular biology ·Ulrich Schopfer, (unknown), (unknown), (unknown), Jennifer A. Leeds, (unknown), (unknown), Sandrine Ferrand, Peter Fekkes, (unknown)	2
12	Closing the Gap between Centralized and Decentralized Compound Management Approaches 2008 ·Combinatorial Chemistry & High Throughput Screening ·(unknown), Thomas Steiner, (unknown), Ulrich Schopfer, Robert A. Smith, (unknown), (unknown), (unknown), (unknown)	2
13	Screening Library Evolution through Automation of Solution Preparation 2007 ·SLAS DISCOVERY ·Ulrich Schopfer, (unknown), (unknown), (unknown), (unknown), (unknown), I. Muckenschnabel	3
14	Compound Hub: Efficiency Gains Through Innovative Sample Management Processes 2007 ·Combinatorial Chemistry & High Throughput Screening ·Ulrich Schopfer, (unknown), (unknown), (unknown), (unknown), M. Girod, (unknown), Thomas Steiner, (unknown), Robert Ross Smith	3
15	Key Aspects of the Novartis Compound Collection Enhancement Project for the Compilation of a Comprehensive Chemogenomics Drug Discovery Screening Collection 2005 ·Current Topics in Medicinal Chemistry ·Edgar Jacoby, Ansgar Schuffenhauer, (unknown), Khalil Azzaoui, (unknown), Ulrich Schopfer, (unknown), Jaroslav Staněk, Pierre Acklin, Pascal Rigollier, Friederike Stoll, Guido Koch, Peter Meier, David Orain, (unknown), (unknown), Karine Malagu, (unknown), (unknown)	51
16	The Novartis Compound Archive - From Concept to Reality 2005 ·Combinatorial Chemistry & High Throughput Screening ·Ulrich Schopfer, (unknown), Jan Staněk, M. Girod, Ansgar Schuffenhauer, Edgar Jacoby, Pierre Acklin	18
17	Molecular Diversity Management Strategies for Building and Enhancement of Diverse and Focused Lead Discovery Compound Screening Collections 2004 ·Combinatorial Chemistry & High Throughput Screening ·Ansgar Schuffenhauer, (unknown), Ulrich Schopfer, Pierre Acklin, J. Staněk, Edgar Jacoby	33
18	Chemically Regulated Zinc Finger Transcription Factors 2000 ·Journal of Biological Chemistry ·Roger R. Beerli, Ulrich Schopfer, Birgit Dreier, Carlos F. Barbas	110
19	Conformational Analysis with Carbon−Carbon Coupling Constants. A Density Functional and Molecular Mechanics Study 1997 ·The Journal of Organic Chemistry ·Martin Ståhl, Ulrich Schopfer, Gernot Frenking, Reinhard W. Hoffmann	25
20	Understanding conformer equilibria in solution with the aid of calculated 13C NMR spectra.1 A density functional and molecular mechanics study 1997 ·Journal of the Chemical Society Perkin Transactions 2 ·Martin Ståhl, Ulrich Schopfer	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact